Inquiry Basket
Loading ......
Filter By Product Search for
CX3CL1
CX3CL1 Full Name
chemokine (C-X3-C motif) ligand 1
CX3CL1 Introduction
Patients and researchers often struggle to understand why inflammation persists even when the original trigger appears to be under control. One molecule that has attracted growing attention in this context is CX3CL1, also known as fractalkine, a unique member of the chemokine family encoded by the CX3CL1 gene. Unlike most chemokines that exist only in soluble form, CX3CL1 can function both as a membrane-bound adhesion molecule and as a soluble chemoattractant. This dual nature allows it to regulate how immune cells communicate, migrate, and remain attached to target tissues. Through its primary receptor, CX3CR1, CX3CL1 serves as a critical signaling bridge between immune cells and tissue-resident cells, particularly within the nervous system, cardiovascular system, and sites of chronic inflammation. Recent research has highlighted its importance as a key regulator of immune surveillance, leukocyte trafficking, and tissue homeostasis, making it an increasingly relevant target in immunology, neuroscience, and translational medicine.
The biological functions of CX3CL1 extend far beyond conventional chemotaxis. Membrane-bound CX3CL1 promotes firm adhesion of leukocytes, while its soluble form recruits immune cells such as monocytes, natural killer cells, T lymphocytes, and microglia to areas of injury or infection. The CX3CL1/CX3CR1 signaling axis is particularly important in neuron–microglia communication, where it helps maintain synaptic stability, regulate neuroinflammatory responses, and preserve normal neural function. Emerging evidence suggests that this pathway can influence oxidative stress responses through mechanisms involving Nrf2-mediated cytoprotective signaling, contributing to cellular resilience during inflammatory challenges. At the same time, the activity of CX3CL1 is highly context-dependent. Depending on tissue type, disease stage, and microenvironmental signals, the pathway may either suppress excessive inflammation or contribute to chronic inflammatory processes. This functional flexibility has positioned CX3CL1 as a central molecular node in studies investigating immune regulation, neuroprotection, tissue remodeling, and host defense mechanisms.
Disease-associated research on CX3CL1 has expanded rapidly in recent years, reflecting its broad clinical relevance. In neurological disorders, dysregulation of the CX3CL1/CX3CR1 axis has been linked to neuroinflammation, cognitive impairment, diabetic encephalopathy, neurodegenerative diseases, and major depressive disorder, where altered neuron–microglia signaling may contribute to synaptic dysfunction and persistent inflammatory responses. In oncology, CX3CL1 demonstrates complex and sometimes opposing effects, with studies reporting roles in both antitumor immune surveillance and tumor-promoting microenvironments depending on cancer type and immune context. Increasing attention has also focused on liver diseases, including metabolic dysfunction-associated steatohepatitis (MASH), viral hepatitis, autoimmune liver disorders, liver fibrosis, and hepatocellular carcinoma, where the CX3CL1/CX3CR1 axis appears to influence inflammatory balance, fibrotic progression, immune suppression, and tumor development. Because of these diverse and context-dependent functions, CX3CL1 is being actively investigated as both a therapeutic target and a potential biomarker for inflammatory, neurodegenerative, metabolic, and malignant diseases. As precision medicine continues to advance, a deeper understanding of CX3CL1 signaling may help researchers identify patient populations most likely to benefit from targeted modulation of this pathway and improve the development of next-generation immunotherapies and anti-inflammatory treatments.
Alternate Names for CX3CL1
CX3CL1; chemokine (C-X3-C motif) ligand 1; NTN; NTT; CXC3; CXC3C; SCYD1; ABCD-3; C3Xkine; fractalkine; neurotactin; fractalkine; C-X3-C motif chemokine 1; small-inducible cytokine D1; CX3C membrane-anchored chemokine; small inducible cytokine subfamily D (Cys-X3-Cys), member-1; small inducible cytokine subfamily D (Cys-X3-Cys), member 1 (fractalkine, neurotactin);
Loading ......
